Copyright
©The Author(s) 2022.
World J Methodol. Sep 20, 2022; 12(5): 402-413
Published online Sep 20, 2022. doi: 10.5662/wjm.v12.i5.402
Published online Sep 20, 2022. doi: 10.5662/wjm.v12.i5.402
Table 4 Criteria for defining osteopenia
Category | Definition | Treatment recommendation |
“Moderate risk”, Endocrine Society guidelines 2019[74] | Clinical: No prior hip or spine fractures, BMD T-score at the hip and spine both above -2.5, 10-yr hip fracture risk < 3% or risk of major osteoporotic fractures < 20% | Reassess fracture risk in 2-4 yr. Country-specific guidelines for treatment |
ISBMR guidelines 2021[75] | BMD T-score between -1.0 and -2.5 at the femoral neck or lumbar spine, 10-yr probability of a hip fracture ≥ 3.5%, or a 10-yr probability of a major osteoporosis-related fracture ≥ 10.5% based on the FRAX tool (based on limited data in Indians) | Advisable to initiate treatment |
- Citation: Mittal M, Jethwani P, Naik D, Garg MK. Non-medicalization of medical science: Rationalization for future. World J Methodol 2022; 12(5): 402-413
- URL: https://www.wjgnet.com/2222-0682/full/v12/i5/402.htm
- DOI: https://dx.doi.org/10.5662/wjm.v12.i5.402